Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SL843P is a human pseudogene identified as a truncated, nonfunctional copy of the 7SL RNA gene, which is the essential RNA component of the signal recognition particle (SRP). SRP functions in protein targeting during cotranslational translocation, but RN7SL843P does not express a functional RNA or protein. Nearly all sequences described as "cytoplasmic 843, pseudogene" are classified as processed pseudogenes, originating from reverse transcription and reintegration events, and do not possess the regulatory sequences or structural integrity required for biological activity[1][4][6]. There are hundreds of similar 7SL RNA pseudogenes in the human genome, but very few retain expression or function. Pseudogenes can occasionally participate in gene conversion or be involved in sequence regulation, but there is no evidence RN7SL843P itself acts in these roles[4][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 843, pseudogene (RN7SL843P).